CT45A5 Protein (Transcript Variant 2) (Myc-DYKDDDDK Tag)

Produktnummer ABIN2717009

Produktdetails

Target: CT45A5 (Cancer/testis Antigen Family 45, Member A5 (CT45A5))

Protein-Typ: Recombinant

Proteineigenschaft: Transcript Variant 2

Spezies: Human

Quelle: HEK-293 Cells

Aufreinigungstag / Konjugat: Dieses CT45A5 Protein ist gelabelt mit Myc-DYKDDDDK Tag.

Applikation: Antibody Production (AbP), Standard (STD)

Produktmerkmale:

• Recombinant human Cancer/testis antigen family 45, member A5 (CT45A5), transcript variant 2. (transcript variant 2) protein expressed in HEK293 cells.
• Produced with end-sequenced ORF clone

Reinheit: > 80 % as determined by SDS-PAGE and Coomassie blue staining

Anwendungsinformationen

Applikationshinweise: Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays

Kommentare:

The tag is located at the C-terminal.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 50 μg/mL

Buffer: 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.

Lagerung: -80 °C

Informationen zur Lagerung: Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.

Antigendetails

Target: CT45A5 (Cancer/testis Antigen Family 45, Member A5 (CT45A5))

Abstract: CT45A5 Produkte

Synonyme: CT45.5 Protein, CT455 Protein, cancer/testis antigen family 45 member A5 Protein, CT45A5 Protein

Hintergrund: This gene represents one of a cluster of several similar genes located on the q arm of chromosome X. The genes in this cluster encode members of the cancer/testis (CT) family of antigens, and are distinct from other CT antigens. These antigens are thought to be novel therapeutic targets for human cancers. Alternative splicing results in multiple transcript variants.

Molekulargewicht: 21.7

NCBI Accession: NP_001165759